European journal of anaesthesiology and intensive care · 2026
Low-concentration norepinephrine in the French operating theatre: A study of daily practices and pharmacological dosages in real-life conditions.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iraqi Manon, Vallée Fabrice, Mateo Joaquim, Mebazaa Alexandre, Weiss Emmanuel, Oliary Juliette, Callebert Jacques, Cartailler Jérome, Joachim Jona
Аннотация
BACKGROUND: Traditionally, ephedrine and phenylephrine have been used to maintain blood pressure during anaesthesia. The use of low-concentration norepinephrine ('baby norepinephrine', bNOR) appears to be increasing.
OBJECTIVES: To better define the current role of norepinephrine in the management of intra-operative hypotension and to identify the challenges associated with its use.
DESIGN: A practice survey (including collection of vasopressor usage data and a questionnaire on the use of bNOR in French operating rooms), combined with pharmacological assessments of norepinephrine dilutions.
SETTING: Vasopressor usage data were collected between 2017 and 2022 in 21 French hospitals. The survey was conducted from July 2021 to April 2022 among anaesthesia personnel within the French-speaking community. Pharmacological analyses were performed in two French university hospitals.
PATIENTS: None.
INTERVENTION: None.
MAIN OUTCOME MEASURES: To assess vasopressor use in operating theatres in France, and to evaluate the accuracy and stability of manually prepared bNOR dilutions.
RESULTS: Usage data demonstrated an increase in norepinephrine use from 28 518 to 59 598 vials (+92.4%), whereas phenylephrine use decreased over the same period from 49 407 vials and prefilled syringes to 14 252 (-71.1%). Survey findings indicated that a majority of respondents (72.5%) use bNOR diluted to concentrations of 10 and 16 μg ml-1. The principal barrier to routine use identified was the risk of dilution inaccuracy. Norepinephrine concentrations were then measured in 16 samples of 10 μg ml-1 and 50 samples of 5 μg ml-1 manually prepared bNOR. Median concentration errors were 10.8% (± 1.34 μg ml-1) for 10 μg ml-1 dilutions and 13.4% (± 0.54 μg ml-1) for 5 μg ml-1 dilutions. Stability testing revealed a reduction in norepinephrine concentration of up to 32% over 24 h.
CONCLUSION: bNOR is emerging as a standard approach for the management of intra-operative hypotension in French operating theatres. However, dilution inaccuracies and stability limitations highlight the need for ready-to-use formulations in order to reduce errors and improve peri-operative care.
OBJECTIVES: To better define the current role of norepinephrine in the management of intra-operative hypotension and to identify the challenges associated with its use.
DESIGN: A practice survey (including collection of vasopressor usage data and a questionnaire on the use of bNOR in French operating rooms), combined with pharmacological assessments of norepinephrine dilutions.
SETTING: Vasopressor usage data were collected between 2017 and 2022 in 21 French hospitals. The survey was conducted from July 2021 to April 2022 among anaesthesia personnel within the French-speaking community. Pharmacological analyses were performed in two French university hospitals.
PATIENTS: None.
INTERVENTION: None.
MAIN OUTCOME MEASURES: To assess vasopressor use in operating theatres in France, and to evaluate the accuracy and stability of manually prepared bNOR dilutions.
RESULTS: Usage data demonstrated an increase in norepinephrine use from 28 518 to 59 598 vials (+92.4%), whereas phenylephrine use decreased over the same period from 49 407 vials and prefilled syringes to 14 252 (-71.1%). Survey findings indicated that a majority of respondents (72.5%) use bNOR diluted to concentrations of 10 and 16 μg ml-1. The principal barrier to routine use identified was the risk of dilution inaccuracy. Norepinephrine concentrations were then measured in 16 samples of 10 μg ml-1 and 50 samples of 5 μg ml-1 manually prepared bNOR. Median concentration errors were 10.8% (± 1.34 μg ml-1) for 10 μg ml-1 dilutions and 13.4% (± 0.54 μg ml-1) for 5 μg ml-1 dilutions. Stability testing revealed a reduction in norepinephrine concentration of up to 32% over 24 h.
CONCLUSION: bNOR is emerging as a standard approach for the management of intra-operative hypotension in French operating theatres. However, dilution inaccuracies and stability limitations highlight the need for ready-to-use formulations in order to reduce errors and improve peri-operative care.